Relay Therapeutics

Relay cuts more staff in efforts to save $50M a year
Fierce Biotech
Thu, 10/3/24 - 09:25 pm
Relay Therapeutics
precision medicine
layoffs
Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap
Fierce Biotech
Mon, 09/9/24 - 11:01 am
Relay Therapeutics
breast cancer
RLY-2608
AstraZeneca
Truqap
clinical trials
Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA
BioSpace
Fri, 10/13/23 - 11:57 am
Relay Therapeutics
cancer
Inflation Reduction Act
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
JPM Day 2: Highlights
BioSpace
Tue, 01/10/23 - 06:50 pm
JPMHC 2023
Relay Therapeutics
Sanofi
Scholar Rock
SAGE Therapeutics
Karuna Therapeutics
GSK
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
ESMO
KRAS inhibitors
Relay Therapeutics
Regeneron
Amgen
Deciphera
Clovis Oncology
Ayala Pharmaceuticals
Springworks
Mirati Therapeutics
Relay kicks off public offering, seeking $300M on heels of robust ESMO data
Endpoints
Mon, 09/12/22 - 10:39 am
ESMO
Relay Therapeutics
funding
ESMO: Relay spotlights expanded FGFR2 inhibitor data it hopes will pave accelerated approval
Fierce Biotech
Sun, 09/11/22 - 10:57 pm
ESMO
Relay Therapeutics
RLY-4008
cholangiocarcinoma
Relay Therapeutics’ Liver Cancer Approach Paying Early Dividends
BioSpace
Sat, 10/9/21 - 11:07 pm
Relay Therapeutics
RLY-4008
intrahepatic cholangiocarcinoma
liver cancer
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
In one of their first ever acquisitions, Relay bets $85M cash on a new AI-based screening approach
Endpoints
Fri, 04/16/21 - 09:51 am
Relay Therapeutics
M&A
ZebiAI
artificial intelligence
drug discovery
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Fierce Biotech
Mon, 12/14/20 - 11:07 am
Genentech
Relay Therapeutics
Roche
KRAS inhibitors
Another huge quarter for biotech flotations
EP Vantage
Fri, 10/2/20 - 12:52 pm
biotech
IPOs
AlloVir
Relay Therapeutics
Nykarta
Dyne Therapeutics
Annexon Biosciences
Relay Therapeutics prices IPO at $400M
MedCity News
Thu, 07/16/20 - 10:47 am
Relay Therapeutics
IPOs
drug discovery
Another four biotechs scratch out the first number and ask for more as IPO boom continues
Endpoints
Fri, 07/10/20 - 11:00 am
IPOs
biotech
Relay Therapeutics
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Xconomy
Thu, 06/25/20 - 10:45 am
Relay Therapeutics
IPOs
protein motion
cancer
Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2018
BioSpace
Tue, 01/7/20 - 10:48 am
Blue Rock Therapeutics
Prelude Fertility
Relay Therapeutics
Relay Therapeutics Banks $400 Million in Series C Round
CP Wire
Thu, 12/20/18 - 10:03 am
Relay Therapeutics
drug discovery
cancer
Relay Therapeutics Banks $400 Million in Series C Round
Thu, 12/20/18 - 09:57 am
Relay Therapeutics